Experimental and clinical studies with a new antimonial preparation for the treatment of schistosomiasis.

Abstract	This paper presents the results of a clinical study in which a new antimony preparation-a chelate of dimethylcysteine with antimony sodium tartrate ("NAP")-was administered intramuscularly at a total dosage of 2 g (5x400 mg, corresponding to 290 mg of Sb) to 400 patients with schistosomiasis. Among 108 patients in a rural population the treatment was on the whole well accepted (97% completed the intensive course of injections), thus indicating that NAP would be useful for the mass treatment of schistosomiasis.
Authors	M R Pedrique, N Ercoli
Journal	Bulletin of the World Health Organization (Bull World Health Organ) Vol. 45 Issue 4 Pg. 411-7 ( 1971) ISSN: 0042-9686 [Print] Switzerland
PMID	5317079 (Publication Type: Journal Article)
Chemical References	Anthelmintics Tartrates Antimony Sodium Potassium
Topics	Adult Anthelmintics (administration & dosage, therapeutic use) Antimony (administration & dosage, therapeutic use) Female Humans Infant, Newborn Male Potassium Schistosomiasis (drug therapy) Sodium Tartrates

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!